Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease

Autor: Détré, Patricia, Bertin, Marie-Jo, Williams, Sabrina, D’Haens, Geert, Vermeire, Severine, Lambrecht, Guy, Baert, Filip, Bossuyt, Peter, Pariente, Benjamin, Buisson, Anthony, Bouhnik, Yoram, Filippi, Jérôme, vander Woude, Janneke, Van Hootegem, Philippe, Moreau, Jacques, Louis, Edouard, Franchimont, Denis, De Vos, Martine, Mana, Fazia, Peyrin-Biroulet, Laurent, Brixi, Hedia, Allez, Matthieu, Caenepeel, Philip, Aubourg, Alexandre, Oldenburg, Bas, Pierik, Marieke, Gils, Ann, Chevret, Sylvie, Laharie, David
Zdroj: In Gastroenterology April 2018 154(5):1343-1351
Databáze: ScienceDirect